May 8, 2018 / 7:54 PM / 2 months ago

BRIEF-Infinity Pharmaceuticals Q1 Loss Per Share $0.18

May 8 (Reuters) - Infinity Pharmaceuticals Inc:

* INFINITY PHARMACEUTICALS SAYS FOR THREE MONTHS ENDED MARCH 31, 2018, DILUTED LOSS PER COMMON SHARE WAS $0.18 - SEC FILING

* Q1 EARNINGS PER SHARE VIEW $-0.18 — THOMSON REUTERS I/B/E/S

* INFINITY PHARMA - BELIEVES EXISTING CASH, CASH EQUIVALENTS & AVAILABLE-FOR-SALE SECURITIES WILL BE ADEQUATE TO SATISFY FORECASTED OPERATING NEEDS INTO Q3 2019

* INFINITY PHARMACEUTICALS - EXPECTS TO CONTINUE TO "INCUR SIGNIFICANT OPERATING LOSSES FOR THE FORESEEABLE FUTURE" Source text: (bit.ly/2KK7bsQ) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below